RU95122160A - METHOD OF OBTAINING NG-MONOALKYL-L-ARGININE AND RELATED COMPOUNDS - Google Patents

METHOD OF OBTAINING NG-MONOALKYL-L-ARGININE AND RELATED COMPOUNDS

Info

Publication number
RU95122160A
RU95122160A RU95122160/04A RU95122160A RU95122160A RU 95122160 A RU95122160 A RU 95122160A RU 95122160/04 A RU95122160/04 A RU 95122160/04A RU 95122160 A RU95122160 A RU 95122160A RU 95122160 A RU95122160 A RU 95122160A
Authority
RU
Russia
Prior art keywords
formula
substituent
compound
takes
pharmaceutically acceptable
Prior art date
Application number
RU95122160/04A
Other languages
Russian (ru)
Other versions
RU2128166C1 (en
Inventor
Пэтел Рэйникэнт
Сингх Мэхэл Эмрик
Ллойд Винстон Берфорд Дональд
Original Assignee
Дзе Веллкам Фаундейшн Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939309321A external-priority patent/GB9309321D0/en
Application filed by Дзе Веллкам Фаундейшн Лимитед filed Critical Дзе Веллкам Фаундейшн Лимитед
Publication of RU95122160A publication Critical patent/RU95122160A/en
Application granted granted Critical
Publication of RU2128166C1 publication Critical patent/RU2128166C1/en

Links

Claims (8)

1. Способ получения соединения формулы (I)
Figure 00000001

или его фармацевтически приемлемой соли или эфира, где заместитель R1 представляет собой С1 - С6-алкил и n принимает значения от 3 до 5, который включает взаимодействие гуанилирующего реагента формулы (II)
Figure 00000002

где заместитель R1 принимает значения, определенные выше,
с соединением формулы (III)
Figure 00000003

или его фармацевтически приемлемой солью или эфиром, где n принимает значения, определенные выше, в присутствии неорганического основания.
1. The method of obtaining the compounds of formula (I)
Figure 00000001

or its pharmaceutically acceptable salt or ether, where the substituent R 1 represents a C 1 - C 6 -alkyl and n takes values from 3 to 5, which includes the interaction guanilating reagent of the formula (II)
Figure 00000002

where the substituent R 1 takes the values defined above,
with a compound of formula (III)
Figure 00000003

or a pharmaceutically acceptable salt or ester thereof, where n is as defined above, in the presence of an inorganic base.
2. Способ по п.1 получения соединения формулы (I) или его фармацевтически приемлемой соли или эфира, где n принимает значения 3 или 4. 2. The method according to claim 1 for preparing a compound of formula (I) or a pharmaceutically acceptable salt or ester thereof, where n is 3 or 4 3. Способ по п.2 получения соединения формулы (I) или его фармацевтически приемлемой соли или эфира, где n принимает значения 3. 3. The method according to claim 2 for preparing a compound of formula (I) or a pharmaceutically acceptable salt or ester thereof, where n is 3. 4. Способ по п.1 получения соединения формулы (I) или его фармацевтически приемлемой соли или эфира, где заместитель R1 представляет собой метил или этил.4. The method according to claim 1 for preparing a compound of formula (I) or a pharmaceutically acceptable salt or ester thereof, wherein the substituent R 1 is methyl or ethyl. 5. Способ по п.4 получения соединения формулы (I) или его фармацевтически приемлемой соли или эфира, где заместитель R1 представляет собой метил.5. The method according to claim 4 for preparing a compound of formula (I) or a pharmaceutically acceptable salt or ester thereof, wherein the substituent R 1 is methyl. 6. Способ по п.1 получения NG-монометил-L-аргинина или его хлористоводородной соли.6. The method according to claim 1 for the preparation of N G- monomethyl-L-arginine or its hydrochloride salt. 7. Способ получения соединения формулы (II)
Figure 00000004

где заместитель R1 принимает значения, определенные выше, который включает окисление соединения формулы (IV)
Figure 00000005

где заместитель R1 принимает значения, определенные выше, а окисляющий агент представляет собой надуксусную кислоту.
7. The method of obtaining the compounds of formula (II)
Figure 00000004

where the substituent R 1 takes the values defined above, which includes the oxidation of compounds of formula (IV)
Figure 00000005

where the substituent R 1 takes the values defined above, and the oxidizing agent is a peracetic acid.
8. Способ получения соединения формулы (I)
Figure 00000006

где заместитель R1 принимает значения, определенные выше, который включает окисление соединения формулы (IV)
Figure 00000007

где окисляющий агент представляет собой надуксусную кислоту, и затем в присутствии неорганической кислоты взаимодействие с соединением формулы (III)
Figure 00000008

где n принимает значения, определенные выше, причем способ проводят без выделения каких-либо промежуточных продуктов.
8. The method of obtaining the compounds of formula (I)
Figure 00000006

where the substituent R 1 takes the values defined above, which includes the oxidation of compounds of formula (IV)
Figure 00000007

where the oxidizing agent is a peracetic acid, and then in the presence of an inorganic acid, the interaction with the compound of the formula (III)
Figure 00000008

where n takes the values defined above, and the method is carried out without isolating any intermediate products.
RU95122160A 1993-05-06 1994-05-05 Method of preparing amino acid n-monoalkyl derivatives and method of preparing n-alkyl-aminoiminomethanesulfonic acid RU2128166C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9309321-9 1993-05-06
GB939309321A GB9309321D0 (en) 1993-05-06 1993-05-06 Process for the preparation of ng-monoalkyl-l-arginine derivatives
PCT/GB1994/000966 WO1994026701A1 (en) 1993-05-06 1994-05-05 Process for preparing ng-monoalkyl-l-arginine and related compounds

Publications (2)

Publication Number Publication Date
RU95122160A true RU95122160A (en) 1997-11-27
RU2128166C1 RU2128166C1 (en) 1999-03-27

Family

ID=10735020

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95122160A RU2128166C1 (en) 1993-05-06 1994-05-05 Method of preparing amino acid n-monoalkyl derivatives and method of preparing n-alkyl-aminoiminomethanesulfonic acid

Country Status (20)

Country Link
US (1) US5840972A (en)
EP (1) EP0696274B1 (en)
JP (1) JPH08509970A (en)
KR (1) KR960701832A (en)
CN (1) CN1122595A (en)
AT (1) ATE187164T1 (en)
AU (1) AU684080B2 (en)
CA (1) CA2162155A1 (en)
CZ (1) CZ286895A3 (en)
DE (1) DE69421916D1 (en)
FI (1) FI955282A (en)
GB (1) GB9309321D0 (en)
HU (1) HU216815B (en)
NO (1) NO954410D0 (en)
NZ (1) NZ265658A (en)
PL (1) PL311582A1 (en)
RU (1) RU2128166C1 (en)
SG (1) SG49904A1 (en)
SK (1) SK138295A3 (en)
WO (1) WO1994026701A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240010627A1 (en) * 2021-01-07 2024-01-11 Peptidream Inc. Novel guanidine derivative and method for producing same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1587258A (en) * 1977-06-17 1981-04-01 Gea As Production of substituted guanidines
US4656291A (en) * 1985-03-15 1987-04-07 Mcneilab, Inc. Process for producing amidine sulfonic acids

Similar Documents

Publication Publication Date Title
RU95117719A (en) DERIVATIVES OF AROIL-PIPERIDINE
RU93005057A (en) PHARMACEUTICAL COMPOUNDS, THYENOBENZODIAZEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION, PHARMOCOMPOSITION AND THEIR USE
DE60117963D1 (en) PROCESS FOR PRODUCING CITALOPRAM
DE59107784D1 (en) Codein salt of a substituted carboxylic acid, process for its preparation, its use and pharmaceutical preparations
ATE90676T1 (en) DIOXYALKYLENARYL-DIHYDROPYRIDINE INTERMEDIATE PRODUCTS FOR THEIR PREPARATION, PROCESS FOR THEIR PREPARATION AND THEIR USE.
RU93049416A (en) DERIVATIVES OF CARBAZOLONA AND METHOD FOR THEIR PRODUCTION
EA199800155A1 (en) NEW CONNECTION
RU93046065A (en) METHOD OF OBTAINING DERIVATIVES OF PHYSOSTYGMINCARBAMATE
FI911080A0 (en) Process for the preparation of 1,5-benzothiazepine derivatives
RU95122160A (en) METHOD OF OBTAINING NG-MONOALKYL-L-ARGININE AND RELATED COMPOUNDS
JPS54160371A (en) Novel piperidine derivative and hypotensive agents comprising it
SE8601799L (en) (-) - 1BETA-ETHYL-1ALFA-HYDROXIMETHYL-1,2,3,4,6,7,12,12BALFA-ICTAHYDROINDOLO / 2,3-A / -KINOLIZINE, PROCEDURES FOR THE PREPARATION OF THE PREPARATION AND
KR940009153A (en) Intermediate compounds for the preparation of antifolate compounds and preparation methods thereof
ATE10844T1 (en) QUINOLINECARBONIC ACID DERIVATIVE, PROCESS FOR ITS PREPARATION AND BACTERICIDES CONTAINING IT.
ES8609322A1 (en) Imidazoquinoline derivatives.
JPS5655397A (en) Aminobenzoic acid ester derivative, and physiologically active agent containing said derivative
RU98113854A (en) ESSENTIAL DERIVATIVES OF TRANS-APOVICAMINIC ACID AS MEDICINES
RU2220145C2 (en) Derivatives of pyrazolopyrimidinone for impotency treatment and method for their preparing
AR014395A1 (en) PROCESS FOR THE PREPARATION OF ACETAL DERIVATIVES OF 1,4-DIHYDROPIRIDINES, NOVEDOUS ACETAL DERIVATIVES, AND THE USE OF ACETAL DERIVATIVES FOR THE PREPARATION OF OTHER 1,4-DIHYDROPIRIDINES
RU98123827A (en) β, β-DESIGNED DERIVATIVES OF 9-DEZOXO-9A-N-ETHENYL-9A-AZA-9A-HOMOERITROMYCIN A
RU99122755A (en) METHOD OF OBTAINING COMPLEX ETHER 2-ALKYLIDENE-4-BROMACETOXIC ACID
JPS6434963A (en) Carbostyril derivative
JPS6438067A (en) 1,4-dihydropyridine derivative labeled with deuterium
RU93004676A (en) DERIVATIVES OF HYDRAZONE, THEIR APPLICATION, METHODS OF OBTAINING, INSECTICIDES AND / OR ACARICIDES CONTAINING THEM AS ACTIVE INGREDIENT AND INTERMEDIATE CONNECTIONS FOR THEIR OBTAINING
JPS56139461A (en) Preparation of alpha-aryl-alpha-alkylpyridineacetic acid amides